Avontec GmbH
Industry
- Biotechnology
- Antisense, Oligonucleotides
- Pharmaceuticals
Latest on Avontec GmbH
1953 was an extraordinary year for biology, an annus mirabilis, or wonder year, which offered scientific insights to rival those made by Einstein almost half a century earlier. It was in this year tha
Inhaled drug delivery Wohraer Strasse 37 D-35285 Gemünden, Germany Phone: +49 6453 64818-0 Web Site: www.activaero.de Contact: Gerhard Scheuch, PhD, Founder & CEO Industry Segment: Pulmonary Drug
The advent of drug-eluting stents has increased the partnering visibility for companies with biocoatings. Ten years ago, SurModics Inc. , one of the few sizeable "pure play" companies in the biocoa
Oligonucleotide Decoys to Treat Inflammatory Disease Göttingen-based start-up Dolthera GMBH aims to develop drugs for inflammatory diseases by interfering with transcription factors, the cellular